Quantres Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-11,300
Closed -$1.93M 188
2018
Q1
$1.93M Buy
11,300
+9,000
+391% +$1.65M 1.17% 19
2017
Q4
$400K Buy
+2,300
New +$407K 0.25% 134
2017
Q2
Sell
-16,600
Closed -$2.72M 184
2017
Q1
$2.72M Buy
+16,600
New +$2.76M 1.76% 8
2016
Q4
Sell
-1,300
Closed -$217K 157
2016
Q3
$217K Buy
+1,300
New +$220K 0.13% 168
2016
Q1
Sell
-1,300
Closed -$211K 126
2015
Q4
$211K Buy
+1,300
New +$204K 0.2% 113
2015
Q3
Sell
-3,900
Closed -$599K 119
2015
Q2
$599K Buy
+3,900
New +$625K 0.47% 70
2015
Q1
Sell
-12,800
Closed -$2.04M 113
2014
Q4
$2.04M Buy
+12,800
New +$1.99M 1.98% 9

Other funds holding AMGN

Quantres Asset Management's AMGN Position: Q2 2018 in Review

Quantres Asset Management sold out of Amgen (AMGN) in Q2 2018, closing a stake of 11,300 shares — an estimated $1.93M sold.

Quantres Asset Management first reported a position in AMGN in Q4 2014 and held it in 7 quarters. The position peaked at $2.72M in Q1 2017. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • Quantres Asset Management reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
  • Quantres Asset Management sold 11,300 Amgen shares in Q2 2018, an estimated $1.93M.
  • Quantres Asset Management first reported a position in Amgen in Q4 2014 and held it in 7 quarters.
  • Quantres Asset Management's Amgen position peaked at $2.72M in Q1 2017.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Quantres Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.